Morphologic studies in a recently described dyserythropoietic state.
D001854:Bone Marrow Cells; D002467:Cell Nucleus; D002470:Cell Survival; D002648:Child; D002842:Chromatids; D002859:Chromium Isotopes; D002869:Chromosome Aberrations; D002900:Chromosomes, Human, 1-3; D003520:Cyclophosphamide / Q000627:therapeutic use; D003593:Cytoplasm; D003630:Daunorubicin / Q000627:therapeutic use; D004592:Electrophoresis, Starch Gel; D004913:Erythrocytes, Abnormal / Q000166:cytology*; D004920:Erythropoiesis; D005319:Fetal Hemoglobin; D006412:Hematopoietic Stem Cells; D006461:Hemolysis; D006801:Humans; D007501:Iron / Q000097:blood; D007621:Karyotyping; D008228:Lymphoma, Non-Hodgkin / Q000097:blood*; D008297:Male; D008533:Megakaryocytes; D008854:Microscopy, Electron; D009996:Osmotic Fragility; D010587:Phagocytosis; D014750:Vincristine / Q000627:therapeutic use
D002859:Chromium Isotopes; D014750:Vincristine; D003520:Cyclophosphamide; D005319:Fetal Hemoglobin; D007501:Iron; D003630:Daunorubicin